ONALI, PIER LUIGI
 Distribuzione geografica
Continente #
EU - Europa 114.895
NA - Nord America 8.457
AS - Asia 1.096
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 4
SA - Sud America 2
Totale 124.475
Nazione #
IT - Italia 112.327
US - Stati Uniti d'America 8.409
UA - Ucraina 1.094
CN - Cina 739
SE - Svezia 614
DE - Germania 284
FI - Finlandia 247
SG - Singapore 228
GB - Regno Unito 191
IN - India 52
FR - Francia 50
CA - Canada 45
KR - Corea 27
RU - Federazione Russa 19
BE - Belgio 13
AU - Australia 12
NL - Olanda 12
IR - Iran 10
HK - Hong Kong 8
VN - Vietnam 8
CH - Svizzera 7
JP - Giappone 7
TR - Turchia 7
EU - Europa 6
HU - Ungheria 5
PT - Portogallo 5
IE - Irlanda 4
RO - Romania 4
BY - Bielorussia 3
ES - Italia 3
IL - Israele 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
BG - Bulgaria 2
DK - Danimarca 2
GT - Guatemala 2
ID - Indonesia 2
LU - Lussemburgo 2
MU - Mauritius 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
CL - Cile 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
IS - Islanda 1
MD - Moldavia 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 124.475
Città #
Cagliari 109.979
Uta 1.985
Fairfield 1.102
Woodbridge 849
Chandler 684
Jacksonville 606
Wilmington 560
Ashburn 559
Houston 555
Boardman 552
Ann Arbor 490
Nyköping 414
Seattle 402
Cambridge 374
Nanjing 189
Singapore 122
Boston 104
Santa Clara 103
Dearborn 91
Helsinki 87
Beijing 82
San Diego 66
Shenyang 51
Hebei 47
Mountain View 45
Shanghai 45
Nanchang 43
Milan 40
Toronto 40
Los Angeles 39
Changsha 36
Tianjin 35
Redwood City 33
Verona 31
Guangzhou 29
Jiaxing 29
Orange 25
New York 23
Ningbo 22
Norwalk 21
London 20
San Mateo 18
Auburn Hills 15
Indiana 15
Jinan 15
Atlanta 13
Brussels 13
Falls Church 13
Zhengzhou 13
Augusta 12
Taizhou 12
Phoenix 11
Borås 10
Leawood 10
Detroit 9
Hefei 9
Walnut 9
Frankfurt am Main 8
Ardabil 7
Chicago 7
Melbourne 7
Munich 7
Pune 7
Rome 7
Kilburn 6
Kunming 6
Millbury 6
Mumbai 6
Tappahannock 6
Monmouth Junction 5
Sassari 5
Seoul 5
St Louis 5
Vila Nova de Gaia 5
Washington 5
Wuhan 5
Budapest 4
Chiswick 4
Dong Ket 4
Dublin 4
Fuzhou 4
Ho Chi Minh City 4
Montefiascone 4
Philadelphia 4
Rockville 4
Salerno 4
Sarroch 4
Shenzhen 4
Zurich 4
Bangalore 3
Cedar Knolls 3
Central 3
Cluj-Napoca 3
Costa Mesa 3
Edinburgh 3
Fremont 3
Hangzhou 3
Mercato San Severino 3
Minsk 3
Naples 3
Totale 121.006
Nome #
Muscarinic acetylcholine receptors potentiate 5'-adenosine monophosphate-activated protein kinase stimulation and glucose uptake triggered by thapsigargin-induced store-operated Ca2+entry in human neuroblastoma cells 3.237
Differential modulation of neurotrophin receptor expression and signaling by Type I Interferons 2.828
Type i interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells 2.665
Type i interferons impair BDNF-induced cell signaling and neurotrophic activity in differentiated human SH-SY5Y neuroblastoma cells and mouse primary cortical neurons 2.513
Evidence that the GABAB positive allosteric modulator CGP7930 activates MAPK cascade independently of GABAB receptor 2.333
Agonist activity of N-desmethylclozapine at delta-opioid receptors of human frontal cortex 2.328
Involvement of store-operated Ca(2+) entry in activation of AMP-activated protein kinase and stimulation of glucose uptake by M3 muscarinic acetylcholine receptors in human neuroblastoma cells. 2.261
δ-Opioid receptors stimulate the metabolic sensor AMP-activated protein kinase through coincident signaling with G(q/11)-coupled receptors. 2.238
Enhancement of human neuroblastoma cell apoptosis by combined treatment with valproic acid and interferonβ 2.233
Protection from interferon-β-induced neuronal apoptosis through stimulation of muscarinic acetylcholine receptors coupled to ERK1/2 activation 2.212
M3 MUSCARINIC ACETYLCHOLINE RECEPTORSACTIVATE THE METABOLIC SENSOR AMP-ACTIVATEDPROTEIN KINASE AND STIMULATE GLUCOSE UPTAKETHROUGH STORE-OPERATED CA2+ ENTRY IN SH-SY5YHUMAN NEUROBLASTOMA CELLS 2.156
Antidepressants activate the lysophosphatidic acid receptor LPA1 to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts 2.145
Involvement of LPA1 lysophosphatidic acid receptor activation in growth factor receptor transactivation by antidepressants 2.143
The atypical antidepressants mianserin and mirtazapine induce ERK1/2 signaling and antiapoptotic effects through activation of the lysophosphatidic acid LPA1 receptor in mouse hippocampal HT22 cells 2.122
Downregulation of TrkB expression and signaling by valproic acid and other histone deacetylase inhibitors 2.117
Interferon-β Inhibits Neurotrophin 3 Signalling and Pro-Survival Activity by Upregulating the Expression of Truncated TrkC-T1 Receptor 2.071
Allosteric modulation of GABA(B) receptor function in human frontal cortex. 2.019
Preclinical and clinical phase I studies of a new recombinant Filgrastim (BK0023) in comparison with Neupogen® 1.933
LPA1 mediates antidepressant-induced ERK1/2 signaling and protection from oxidative stress in glial cells 1.920
Interferon-β counter-regulates its own pro-apoptotic action by activating p38 MAPK signalling in human SH-SY5Y neuroblastoma cells 1.892
LPA1is a key mediator of intracellular signalling and neuroprotection triggered by tetracyclic antidepressants in hippocampal neurons 1.839
Structural and functional characterization of site-specific PEGylated r-met-h-G-CSF 1.738
The GABAB positive allosteric modulators CGP7930 and GS39783 stimulate ERK1/2 signalling in cells lacking functional GABAB receptors 1.701
Inhibition of TNF-α-induced neuronal apoptosis by antidepressants acting through the lysophosphatidic acid receptor LPA1 1.656
Coincidence signaling of dopamine D1-like and M1 muscarinic receptors in the regulation of cyclic AMP formation and CREB phosphorylation in mouse prefrontal cortex 1.594
Potentiation of dopamine D1-like receptor signaling by concomitant activation of δ- And μ-opioid receptors in mouse medial prefrontal cortex 1.588
null 1.558
null 1.498
Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3beta by the recombinant human delta-opioid receptor stably expressed in Chinese hamster ovary cells 1.370
Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes 1.358
The atypical antidepressant mianserin exhibits agonist activity at kappa-opioid receptors 1.355
Enzymatic mono-pegylation of glucagon-like peptide 1 towards long lasting treatment of type 2 diabetes 1.349
null 1.341
null 1.309
Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of delta-opioid receptor 1.284
null 1.194
Activation of µ- and ð-opioid receptors enhances dopamine D1-like receptor signalling in mouse medial prefrontal cortex. 1.192
Delta-opioid receptors stimulate GLUT1-mediated glucose uptake through Src- and IGF-1 receptor-dependent activation of PI3-kinase signalling in CHO cells 1.167
Interferon-beta induces apoptosis in human SH-SY5Y neuroblastoma cells through activation of JAK-STAT signaling and down-regulation of PIK-Akt pathway 1.156
null 1.148
Antidepressants activate LPA1 lysophosphatidic acid receptor to induce growth factor receptor transactivation 1.080
Activation of nociceptin/orphanin FQ-NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D1 receptor signalling in rat nucleus accumbens and dorsal striatum 1.037
Upregulation of p75NTR by Histone Deacetylase Inhibitors Sensitizes Human Neuroblastoma Cells to Targeted Immunotoxin-Induced Apoptosis 1.027
null 919
null 882
null 845
null 841
Proteinase-activated receptors 1 and 2 in rat olfactory system: layer-specific regulation of multiple signaling pathways in the main olfactory bulb and induction of neurite retraction in olfactory sensory neurons 818
null 817
N-desmethylclozapine, a major clozapine metabolite, regulates glycogen synthase 3-β through stimulation of ð opioid receptors and PI3 kìnase/AKt pathway. 816
null 794
null 755
RGS proteins 4 and 9 regulate µ-opioid receptor-induced potentiation of dopamine D1-like receptor signaling in mouse medial prefrontal cortex. 753
Evidence of pituitary adenylate cyclase activating polypeptide (PACAP)in pancreatic islet cells by confocal microscopy 743
Stimulation of cyclic AMP formation and nerve electrical activity by octopamine in the terminal abdominal ganglion of the female gypsy moth Limantria dispar 742
Stimulation of proteinase-activated receptors 1 and 2 induces neurodegeneration in the rat olfactory system. 735
Agonist activity of N-Desmethylclozapine, a major clozapine metabolite, at delta opioid receptors. 701
Expression and functional activity of proteinase-activated receptors 1 and 2 in the rat olfactory 681
N-Desmethylclozapine, a major clozapine metabolite, acts as a selective and effecacious delta-opioid agonist at recombinant and native receptors 643
DUAL COUPLING OF OPIOID RECEPTOR-LIKE (ORL1) RECEPTORS TO ADENYLYL CYCLASE IN THE DIFFERENT LAYERS OF THE RAT MAIN OLFACTORY BULB 635
null 633
Destruction of post-synaptic dopamine receptors prevents neuroleptic-induced activation of striatal tyrosine hydroxylase but not dopamine synthesis stimulation. 616
Expression of pituitary adenylate cyclase-activating polypeptide (PACAP)receptors and PACAP in human fetal retina 616
Expression and signalling of protease-activated receptors in distinct layers of rat olfactory bulb and olfactory sensory neurons. 615
Production of interferon-β (INF-β) in E. coli and strategies for improving its bioavailability and pharmacological profile. 592
PEGylation of Recombinant Human Granulocyte Colony-Stimulating Factor (r-h-G-CSF) Produced in Escherichia coli: a New Drug to Overcome Neutropenia 581
Stress induced increase in 3,4 dihydroxyphenylacetic acid (DOPAC)levels in the cerebral cortex and n.accumbens: reversal by diazepam. 556
Expression and signalling mechanism of muscarinic M2 receptor in rat accessory olfacory bulb. 546
Involvement of store-operated Ca2+ entry in AMP-activated protein kinase stimulation by Gq/11-coupled receptors 521
Human delta opioid receptors stimulate AMP-activated protein kinase through coincident signaling with Gq/11-coupled receptors 506
Snake toxins that bind to muscarinic acetylcholine receptors 492
Evidence for dopamine receptors in the human brain mediating sedation and sleep 481
Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors 466
Activation of M3 muscarinic acetylcholine receptors protects against interferon-β-induced neuronal cell death. 44th Meeting of the Society for Neuroscience. 15-19 November 2014 Washington, U.S.A. 451
Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors 448
[Phe(1)Phi(CH2-NH)Gly(2)]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells 444
G PROTEIN ACTIVATION AND CYCLIC AMP MODULATION BY NALOXONE BENZOYLHYDRAZONE IN DISTINCT LAYERS OF RAT OLFACTORY BULB 421
Interferon-β alters neurotrophin-3 TrkC receptor expression and signaling in differentiated human SH-SY5Y neuroblastoma cells 420
Tricyclic and tetracyclic antidepressants activate LPA1 lysophosphatidic acid receptor signaling in glial cells. 44th Meeting of the Society for Neuroscience. 15-19 November 2014 Washington, U.S.A. 417
Antidepressants induce profibrotic responses via the lysophosphatidic acid receptor LPA1 395
Type I interferons upregulate p75 neurotrophin receptor expression and signaling in human neuroblastoma cells. 394
Role of G protein betagamma subunits in muscarinic receptor-induced stimulation and inhibition of adenylyl cyclase activity in rat olfactory bulb 390
Muscarinic receptors modulate dopamine-activated adenylate cyclase of rat striatum 389
Regulation of AMP-activated protein kinase by human delta opioid receptors 389
Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists. 384
Inhibition of striatal adenylate cyclase activity by stimulation of muscarinic receptors 384
Long-term effect of kainic acid on striatal dopaminergic neurons 375
Interferon-β impairs BDNF-induced neuronal signaling and differentiation. 373
MUSCARINIC M4 RECEPTOR INHIBITION OF DOPAMINE D1-LIKE RECEPTOR SIGNALLING IN RAT NUCLEUS ACCUMBENS 354
THE PHARMACOLOGICAL ACTION OF MT-7 341
Sodium ions and GTP decrease the potency of [Nphe1]N/OFQ(1-13) NH2 in blocking nociceptin/orphanin FQ receptors coupled to cyclic AMP in N1E-115 neuroblastoma cells and rat olfactory bulb 337
Dopamine receptors stimulate high affinity GTPase(s) in rat striatum 335
The effects of GBL and AP28 on brain dopamine metabolism: a comparative study. 333
Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary 328
Stress-induced increase in 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in n. accumbens: reversal by diazepam 326
Dopaminergic modulation of adenylate cyclase stimulated by vasoactive intestinal peptide in male rat anterior pituitary 322
Beta-adrenergic regulation of a Ca++-independent cAMP specific cyclic nucleotide phosphodiesterase in C6 glioma cells. 320
BETA/GAMMA-MEDIATED ENHANCEMENT OF CORTICOTROPIN-RELEASING HORMONE-STIMULATED ADENYLYL CYCLASE ACTIVITY BY ACTIVATION OF GAMMA-AMINOBUTYRIC ACID B RECEPTORS IN MEMBRANES OF RAT FRONTAL CORTEX 312
Interferon-β activates neuronal signaling pathways associated with stress and depression 307
Possibile role of insulin in the transport of tyrosine and tryptophan from blood to brain 305
Totale 107.240
Categoria #
all - tutte 168.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021.241 0 0 0 0 9.315 5.532 3.332 833 624 401 523 681
2020/202131.256 977 884 1.113 8.603 7.053 3.120 3.961 1.718 511 1.099 929 1.288
2021/20226.217 912 493 278 506 591 353 240 397 483 527 835 602
2022/202310.353 832 1.111 953 807 642 968 680 1.163 930 783 969 515
2023/202411.838 681 807 503 822 1.167 1.516 1.713 794 470 908 1.305 1.152
2024/202515.106 4.993 5.038 2.292 1.821 962 0 0 0 0 0 0 0
Totale 124.706